Chugai Pharmaceutical Co., Ltd.
4519
Classificação em ações
#356
Chugai Pharmaceutical Co., Ltd. is a prominent global pharmaceutical company,... Chugai Pharmaceutical Co., Ltd. is a prominent global pharmaceutical company, operating subsidiaries involved in the full lifecycle of drug development, from research and manufacturing to sales, import, and export, serving both Japanese and international markets. Its commercialized product portfolio spans several key therapeutic areas. These include a robust oncology offering with leading treatments like Avastin, Tecentriq, Perjeta, Alecensa, Herceptin, Kadcyla, Rituxan, Gazyva, and Xeloda. Additionally, it provides medications for bone health (e.g., Actemra, Edirol, Bonviva), renal conditions (such as Mircera and Oxarol), and neurological or other diverse ailments (including Hemlibra, CellCept, and Enspryng). Beyond its existing offerings, the company maintains an active research and development pipeline. This pipeline features multiple promising candidates targeting oncology, orthopedic and joint disorders, autoimmune diseases, kidney-related conditions, and various neurological or other health issues. Strategic partnerships are central to Chugai's operations, most notably a significant alliance with the Roche Group. The company also fosters collaborative research initiatives with academic institutions. Established in 1925, Chugai's headquarters are located in Tokyo, Japan, and it operates as a key subsidiary of Roche Holding Ltd.
Preço da ação
$41.71
Última sincronização: 2026-10-16
Valor de mercado
$68.64B
Variação (1 dia)
2.01%
Variação (1 ano)
-14.16%
País
JP
Negociar Chugai Pharmaceutical Co., Ltd. (4519)
Categoria
Healthcare
Capitalização de mercado de Chugai Pharmaceutical Co., Ltd.(4519)
Valor de mercado: $68.64B
Em October 2026, Chugai Pharmaceutical Co., Ltd. tem uma capitalização de mercado de $68.64B. Isso faz com que Chugai Pharmaceutical Co., Ltd. seja a 356th empresa mais valiosa do mundo em termos de capitalização de mercado, de acordo com os nossos dados. A capitalização de mercado, também chamada de market cap, é o valor total de mercado das ações em circulação de uma empresa de capital aberto e é amplamente utilizada para medir o valor de uma empresa.
Histórico de capitalização de mercado de Chugai Pharmaceutical Co., Ltd. de 2000 a 2026
4519 comparado com o topo de 5 mais populares stocks
